Richards Group (RIC) Q1 2025 earnings summary

Executive summary

• Q1 2025 revenue increased by $2.8M (2.9%) year-over-year, reversing recent declines.

• Net income decreased by $3.4M due to exceptional items and higher lease and administrative costs.

• Food & Beverage packaging revenues grew 5%, Cosmetics up 3%, while Healthcare declined 2.7% year-over-year.

• Two tuck-in acquisitions (HL Production and National Dental Innovations) completed, expected to contribute earnings from Q2.

• The passing of the longtime CEO marked a significant leadership transition.

Financial highlights

• Revenue: $100.7M (Q1 2025) vs $97.9M (Q1 2024).

• Net income: $5.1M (Q1 2025) vs $8.5M (Q1 2024); diluted EPS $0.36 vs $0.76.

• Adjusted EBITDA: $12.0M (12% of sales), down $1.3M year-over-year.

• Gross margin declined to 19.3% from 20.1% due to higher lease payments.

• Distributable cash flow per unit up to $0.86; payout ratio at 39%.

Outlook and guidance

• Management expects to sustain monthly distributions at current levels through 2025.

• Healthcare revenue decline expected to continue in Q2, partially offset by new acquisitions.

• Lease and administrative expenses projected to remain stable in Q2.

• Surplus distributable cash in Q2 will be used to pay down revolving debt.